newsfilter
← Latest News
GlobeNewswire·

Conformis, Inc. Announces Settlement of Medacta Patent Litigation

BILLERICA, Mass., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that it has entered into a settlement and license agreement with Medacta USA, Medacta Germany GmbH, and Medacta